

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 6.10060195 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.80214070 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 5.67206255 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.52770351 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.52770351 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.39199820 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.39199820 |
| 8 | regulation of triglyceride catabolic process (GO:0010896) | 5.24617023 |
| 9 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.95238832 |
| 10 | valine metabolic process (GO:0006573) | 4.77936796 |
| 11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.75687944 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.72699150 |
| 13 | fatty acid transmembrane transport (GO:1902001) | 4.71526226 |
| 14 | fatty acid beta-oxidation (GO:0006635) | 4.67798128 |
| 15 | positive regulation of fatty acid oxidation (GO:0046321) | 4.64640306 |
| 16 | plasma lipoprotein particle clearance (GO:0034381) | 4.61878071 |
| 17 | biotin metabolic process (GO:0006768) | 4.61049522 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.60161076 |
| 19 | acetyl-CoA metabolic process (GO:0006084) | 4.51760345 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.49440188 |
| 21 | positive regulation of lipid catabolic process (GO:0050996) | 4.48028842 |
| 22 | low-density lipoprotein particle clearance (GO:0034383) | 4.47289795 |
| 23 | lysine catabolic process (GO:0006554) | 4.46695907 |
| 24 | lysine metabolic process (GO:0006553) | 4.46695907 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.40163909 |
| 26 | fatty acid oxidation (GO:0019395) | 4.39671646 |
| 27 | carnitine shuttle (GO:0006853) | 4.36299224 |
| 28 | triglyceride homeostasis (GO:0070328) | 4.33958132 |
| 29 | acylglycerol homeostasis (GO:0055090) | 4.33958132 |
| 30 | lipid oxidation (GO:0034440) | 4.32450276 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.32320457 |
| 32 | bile acid biosynthetic process (GO:0006699) | 4.30355761 |
| 33 | fatty acid catabolic process (GO:0009062) | 4.29607608 |
| 34 | triglyceride catabolic process (GO:0019433) | 4.29581231 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.25906486 |
| 36 | cysteine metabolic process (GO:0006534) | 4.21661279 |
| 37 | lipid storage (GO:0019915) | 4.19819836 |
| 38 | acylglycerol catabolic process (GO:0046464) | 4.18774690 |
| 39 | neutral lipid catabolic process (GO:0046461) | 4.18774690 |
| 40 | urea cycle (GO:0000050) | 4.18259190 |
| 41 | urea metabolic process (GO:0019627) | 4.18259190 |
| 42 | short-chain fatty acid metabolic process (GO:0046459) | 4.17501223 |
| 43 | branched-chain amino acid catabolic process (GO:0009083) | 4.15779197 |
| 44 | kynurenine metabolic process (GO:0070189) | 4.10879847 |
| 45 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.09137385 |
| 46 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.07940733 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.04368981 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.04368981 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.04368981 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 4.02275952 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 4.02275952 |
| 52 | tryptophan catabolic process (GO:0006569) | 4.02275952 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.01277469 |
| 54 | negative regulation of fibrinolysis (GO:0051918) | 4.00726655 |
| 55 | regulation of fatty acid oxidation (GO:0046320) | 3.99937805 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 3.98377058 |
| 57 | branched-chain amino acid metabolic process (GO:0009081) | 3.98152165 |
| 58 | monocarboxylic acid catabolic process (GO:0072329) | 3.98078870 |
| 59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.96481968 |
| 60 | protein carboxylation (GO:0018214) | 3.96481968 |
| 61 | regulation of cholesterol esterification (GO:0010872) | 3.93778360 |
| 62 | reverse cholesterol transport (GO:0043691) | 3.90412463 |
| 63 | positive regulation of heat generation (GO:0031652) | 3.89989833 |
| 64 | nitrogen cycle metabolic process (GO:0071941) | 3.87142729 |
| 65 | serine family amino acid catabolic process (GO:0009071) | 3.85572446 |
| 66 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.84189318 |
| 67 | regulation of protein activation cascade (GO:2000257) | 3.82921658 |
| 68 | acyl-CoA biosynthetic process (GO:0071616) | 3.81991089 |
| 69 | thioester biosynthetic process (GO:0035384) | 3.81991089 |
| 70 | tryptophan metabolic process (GO:0006568) | 3.81521512 |
| 71 | response to peptidoglycan (GO:0032494) | 3.78390689 |
| 72 | negative regulation of lipase activity (GO:0060192) | 3.77341617 |
| 73 | regulation of fibrinolysis (GO:0051917) | 3.77069059 |
| 74 | ethanol oxidation (GO:0006069) | 3.76702651 |
| 75 | carnitine metabolic process (GO:0009437) | 3.76403261 |
| 76 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.75811271 |
| 77 | negative regulation of lipid storage (GO:0010888) | 3.74466905 |
| 78 | bile acid metabolic process (GO:0008206) | 3.73974825 |
| 79 | positive regulation of lipid storage (GO:0010884) | 3.71266985 |
| 80 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.70596944 |
| 81 | phospholipid efflux (GO:0033700) | 3.70178145 |
| 82 | regulation of triglyceride metabolic process (GO:0090207) | 3.69282035 |
| 83 | alpha-amino acid catabolic process (GO:1901606) | 3.68495894 |
| 84 | phospholipid homeostasis (GO:0055091) | 3.66807576 |
| 85 | regulation of fever generation (GO:0031620) | 3.65100055 |
| 86 | homocysteine metabolic process (GO:0050667) | 3.63896453 |
| 87 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.63410802 |
| 88 | regulation of complement activation (GO:0030449) | 3.60031468 |
| 89 | brown fat cell differentiation (GO:0050873) | 3.59772590 |
| 90 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.59215816 |
| 91 | linoleic acid metabolic process (GO:0043651) | 3.58067712 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58014729 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58014729 |
| 94 | tyrosine metabolic process (GO:0006570) | 3.56850461 |
| 95 | carboxylic acid catabolic process (GO:0046395) | 3.56549058 |
| 96 | organic acid catabolic process (GO:0016054) | 3.56549058 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 3.55143430 |
| 98 | fatty acid homeostasis (GO:0055089) | 3.50685275 |
| 99 | carnitine transmembrane transport (GO:1902603) | 3.48124557 |
| 100 | ketone body metabolic process (GO:1902224) | 3.44219697 |
| 101 | acyl-CoA metabolic process (GO:0006637) | 3.43894621 |
| 102 | thioester metabolic process (GO:0035383) | 3.43894621 |
| 103 | triglyceride metabolic process (GO:0006641) | 3.41955475 |
| 104 | aromatic amino acid family metabolic process (GO:0009072) | 3.40499517 |
| 105 | positive regulation of cholesterol efflux (GO:0010875) | 3.39314791 |
| 106 | regulation of cholesterol storage (GO:0010885) | 3.39173857 |
| 107 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.38915760 |
| 108 | coenzyme catabolic process (GO:0009109) | 3.37945352 |
| 109 | negative regulation of cholesterol transport (GO:0032375) | 3.37611185 |
| 110 | negative regulation of sterol transport (GO:0032372) | 3.37611185 |
| 111 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.37512709 |
| 112 | regulation of cholesterol metabolic process (GO:0090181) | 3.36050021 |
| 113 | amino-acid betaine transport (GO:0015838) | 3.35953212 |
| 114 | regulation of vitamin metabolic process (GO:0030656) | 3.35470145 |
| 115 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.33086095 |
| 116 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.32843863 |
| 117 | negative regulation of interleukin-12 production (GO:0032695) | 3.24287931 |
| 118 | regulation of lipid storage (GO:0010883) | 3.22537610 |
| 119 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.18637173 |
| 120 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.05734067 |
| 121 | germinal center formation (GO:0002467) | 3.04630274 |
| 122 | diacylglycerol metabolic process (GO:0046339) | 3.03380979 |
| 123 | NADH metabolic process (GO:0006734) | 2.99225318 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.99147868 |
| 125 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.97036556 |
| 126 | negative regulation of amino acid transport (GO:0051956) | 2.96183773 |
| 127 | transcytosis (GO:0045056) | 2.94484604 |
| 128 | regulation of mononuclear cell migration (GO:0071675) | 2.85450567 |
| 129 | regulation of heat generation (GO:0031650) | 2.83439999 |
| 130 | positive regulation of sterol transport (GO:0032373) | 2.82414005 |
| 131 | positive regulation of cholesterol transport (GO:0032376) | 2.82414005 |
| 132 | glycerolipid catabolic process (GO:0046503) | 2.81527897 |
| 133 | triglyceride biosynthetic process (GO:0019432) | 2.81474868 |
| 134 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.79453893 |
| 135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.78800250 |
| 136 | positive regulation of acute inflammatory response (GO:0002675) | 2.78624687 |
| 137 | barbed-end actin filament capping (GO:0051016) | 2.78381560 |
| 138 | cellular response to epinephrine stimulus (GO:0071872) | 2.75644097 |
| 139 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.74565439 |
| 140 | detection of molecule of bacterial origin (GO:0032490) | 2.74475390 |
| 141 | neutrophil activation involved in immune response (GO:0002283) | 2.72009154 |
| 142 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.71831571 |
| 143 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.71301175 |
| 144 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.67468839 |
| 145 | macrophage activation involved in immune response (GO:0002281) | 2.65779834 |
| 146 | neutral lipid biosynthetic process (GO:0046460) | 2.64370453 |
| 147 | acylglycerol biosynthetic process (GO:0046463) | 2.64370453 |
| 148 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.63674630 |
| 149 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61835860 |
| 150 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61251190 |
| 151 | NIK/NF-kappaB signaling (GO:0038061) | 2.59682121 |
| 152 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.59280334 |
| 153 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.57349507 |
| 154 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56683428 |
| 155 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.54300113 |
| 156 | response to muramyl dipeptide (GO:0032495) | 2.52867102 |
| 157 | lymphocyte chemotaxis (GO:0048247) | 2.51754663 |
| 158 | regulation of chronic inflammatory response (GO:0002676) | 2.50628045 |
| 159 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.49966430 |
| 160 | response to progesterone (GO:0032570) | 2.48981581 |
| 161 | cellular response to lipopolysaccharide (GO:0071222) | 2.48496950 |
| 162 | ovulation from ovarian follicle (GO:0001542) | 2.47410886 |
| 163 | type I interferon signaling pathway (GO:0060337) | 2.47183671 |
| 164 | cellular response to type I interferon (GO:0071357) | 2.47183671 |
| 165 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.46451629 |
| 166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.46422723 |
| 167 | negative regulation of lipid catabolic process (GO:0050995) | 2.45269399 |
| 168 | regulation of podosome assembly (GO:0071801) | 2.45191254 |
| 169 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.45141825 |
| 170 | ovulation (GO:0030728) | 2.44252093 |
| 171 | adhesion of symbiont to host cell (GO:0044650) | 2.44015837 |
| 172 | virion attachment to host cell (GO:0019062) | 2.44015837 |
| 173 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.42759452 |
| 174 | response to type I interferon (GO:0034340) | 2.42438214 |
| 175 | negative regulation of protein autophosphorylation (GO:0031953) | 2.42218701 |
| 176 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.41720766 |
| 177 | cellular response to arsenic-containing substance (GO:0071243) | 2.41422864 |
| 178 | cellular response to molecule of bacterial origin (GO:0071219) | 2.41084507 |
| 179 | oxaloacetate metabolic process (GO:0006107) | 2.39823699 |
| 180 | regulation of necrotic cell death (GO:0010939) | 2.38324994 |
| 181 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.37815637 |
| 182 | regulation of tumor necrosis factor production (GO:0032680) | 2.37379817 |
| 183 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.37373627 |
| 184 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.34715535 |
| 185 | positive regulation of fat cell differentiation (GO:0045600) | 2.34225958 |
| 186 | cellular extravasation (GO:0045123) | 2.33768445 |
| 187 | regulation of gonadotropin secretion (GO:0032276) | 2.33453154 |
| 188 | defense response to protozoan (GO:0042832) | 2.32834240 |
| 189 | response to manganese ion (GO:0010042) | 2.32826162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.53604617 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.32249291 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.85652265 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.94389685 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.51595643 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.78231748 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.44876046 |
| 8 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.20345033 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.92313998 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.82414099 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.63894607 |
| 12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.97516408 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.68475161 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40771783 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36566426 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.35945481 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27275548 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17806889 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07112135 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06655650 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94253764 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88296886 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.85641767 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82090388 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81295611 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79604601 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77758924 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.72437759 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72349411 |
| 30 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71849111 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67575079 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66811805 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56301290 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53268689 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51550962 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51219816 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47952887 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46189823 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43683428 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43408749 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.42104622 |
| 42 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40509198 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39032148 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36927439 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35586648 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34583090 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33269956 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30771432 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29717935 |
| 50 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.28712016 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27286089 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26810945 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21072478 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19311561 |
| 55 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18443228 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17609086 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17557917 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16238900 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.15659341 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14338339 |
| 61 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13925420 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13887181 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13461702 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12343561 |
| 65 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11847933 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11578906 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11503384 |
| 68 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11175395 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10855614 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10168112 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09820337 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08632365 |
| 73 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.07648690 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07403007 |
| 75 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06476133 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06326396 |
| 77 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05644367 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04648062 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03841306 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03841306 |
| 81 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03681213 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02674185 |
| 83 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02641955 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01581204 |
| 85 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00579683 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00490677 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00374703 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98388586 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97631495 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97478081 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97291797 |
| 92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97190370 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97190370 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96348811 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96029293 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96023825 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95131509 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94867718 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94811756 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94594301 |
| 101 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93866673 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90985052 |
| 103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88864844 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87740881 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87740881 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87449541 |
| 107 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87149967 |
| 108 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86986261 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86647443 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85222167 |
| 111 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81700448 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80120377 |
| 113 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.79703045 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77490374 |
| 115 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76950921 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76928827 |
| 117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76602241 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76350517 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75304559 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75141757 |
| 121 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74532555 |
| 122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.73470731 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70100097 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69372202 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64803719 |
| 126 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63973486 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62800852 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.62253498 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.62014443 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.60190821 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.59501505 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59113982 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58797351 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58587932 |
| 135 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.57798238 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57722256 |
| 137 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.57473651 |
| 138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.56860082 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56753831 |
| 140 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56701221 |
| 141 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54829653 |
| 142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54387405 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.54175263 |
| 144 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52931028 |
| 145 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.52256687 |
| 146 | CJUN_26792858_Chip-Seq_BT549_Human | 0.51886528 |
| 147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.51661629 |
| 148 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.51320313 |
| 149 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.50684805 |
| 150 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.50390234 |
| 151 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49567899 |
| 152 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.47325656 |
| 153 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47284246 |
| 154 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.46991158 |
| 155 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.46260655 |
| 156 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46081209 |
| 157 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.44956895 |
| 158 | AR_20517297_ChIP-Seq_VCAP_Human | 0.44774451 |
| 159 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.43718855 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43682865 |
| 161 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.43532562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.50832943 |
| 2 | MP0005360_urolithiasis | 5.62817279 |
| 3 | MP0005365_abnormal_bile_salt | 5.03701230 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.81142858 |
| 5 | MP0003303_peritoneal_inflammation | 4.23273433 |
| 6 | MP0005670_abnormal_white_adipose | 3.95218222 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.74334066 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.68511745 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.18414287 |
| 10 | MP0004130_abnormal_muscle_cell | 3.11226127 |
| 11 | MP0004510_myositis | 2.93421808 |
| 12 | MP0003252_abnormal_bile_duct | 2.74840700 |
| 13 | MP0003436_decreased_susceptibility_to | 2.70315136 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.66578780 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.61132550 |
| 16 | MP0009840_abnormal_foam_cell | 2.60021168 |
| 17 | MP0005332_abnormal_amino_acid | 2.57780587 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.44340516 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.43521422 |
| 20 | MP0005083_abnormal_biliary_tract | 2.33087425 |
| 21 | MP0003075_altered_response_to | 2.22042930 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.20223903 |
| 23 | MP0009785_altered_susceptibility_to | 2.18498216 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.17496830 |
| 25 | MP0000609_abnormal_liver_physiology | 2.11065521 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 2.10247277 |
| 27 | MP0002971_abnormal_brown_adipose | 1.94570825 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.91787295 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.91707864 |
| 30 | MP0003828_pulmonary_edema | 1.90083960 |
| 31 | MP0003195_calcinosis | 1.88824831 |
| 32 | MP0001881_abnormal_mammary_gland | 1.88706523 |
| 33 | MP0008004_abnormal_stomach_pH | 1.82486088 |
| 34 | MP0002419_abnormal_innate_immunity | 1.81929888 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.78043406 |
| 36 | MP0006082_CNS_inflammation | 1.77865383 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.77469455 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.76611141 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.74151528 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.70754918 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.64216682 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61477276 |
| 43 | MP0005025_abnormal_response_to | 1.60152216 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.58089756 |
| 45 | MP0009278_abnormal_bone_marrow | 1.57713832 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.57343563 |
| 47 | MP0003186_abnormal_redox_activity | 1.56496130 |
| 48 | MP0001764_abnormal_homeostasis | 1.54133389 |
| 49 | MP0004947_skin_inflammation | 1.53057818 |
| 50 | MP0000858_altered_metastatic_potential | 1.50635796 |
| 51 | MP0005334_abnormal_fat_pad | 1.47963229 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.46303479 |
| 53 | MP0003011_delayed_dark_adaptation | 1.45891182 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.44195071 |
| 55 | MP0005387_immune_system_phenotype | 1.41058295 |
| 56 | MP0001790_abnormal_immune_system | 1.41058295 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.39415435 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.38152302 |
| 59 | MP0005166_decreased_susceptibility_to | 1.35055975 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.34331190 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.34331190 |
| 62 | MP0009115_abnormal_fat_cell | 1.26245528 |
| 63 | MP0005535_abnormal_body_temperature | 1.25787084 |
| 64 | MP0003950_abnormal_plasma_membrane | 1.25762966 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.24894814 |
| 66 | MP0002254_reproductive_system_inflammat | 1.24394685 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.24346551 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.24148746 |
| 69 | MP0005451_abnormal_body_composition | 1.22521829 |
| 70 | MP0003448_altered_tumor_morphology | 1.20713159 |
| 71 | MP0003646_muscle_fatigue | 1.19678635 |
| 72 | MP0005165_increased_susceptibility_to | 1.18786052 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.17689041 |
| 74 | MP0002723_abnormal_immune_serum | 1.17199285 |
| 75 | MP0001661_extended_life_span | 1.15240998 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 1.13619703 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.12856605 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.08369117 |
| 79 | MP0002970_abnormal_white_adipose | 1.07448709 |
| 80 | MP0005275_abnormal_skin_tensile | 1.03470888 |
| 81 | MP0001542_abnormal_bone_strength | 1.01698583 |
| 82 | MP0001800_abnormal_humoral_immune | 1.00934718 |
| 83 | MP0005464_abnormal_platelet_physiology | 0.99869757 |
| 84 | MP0005330_cardiomyopathy | 0.99740911 |
| 85 | MP0010368_abnormal_lymphatic_system | 0.99608966 |
| 86 | MP0000598_abnormal_liver_morphology | 0.98468944 |
| 87 | MP0005448_abnormal_energy_balance | 0.97661423 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.97157595 |
| 89 | MP0003690_abnormal_glial_cell | 0.96994175 |
| 90 | MP0005023_abnormal_wound_healing | 0.95444315 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.95315855 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.95205163 |
| 93 | MP0001819_abnormal_immune_cell | 0.95141864 |
| 94 | MP0002420_abnormal_adaptive_immunity | 0.95021827 |
| 95 | MP0002933_joint_inflammation | 0.94798195 |
| 96 | MP0005647_abnormal_sex_gland | 0.94299185 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.93275491 |
| 98 | MP0000685_abnormal_immune_system | 0.93187911 |
| 99 | MP0003724_increased_susceptibility_to | 0.91583559 |
| 100 | MP0005390_skeleton_phenotype | 0.91432247 |
| 101 | MP0003091_abnormal_cell_migration | 0.91363145 |
| 102 | MP0009763_increased_sensitivity_to | 0.90422562 |
| 103 | MP0002405_respiratory_system_inflammati | 0.89991503 |
| 104 | MP0000759_abnormal_skeletal_muscle | 0.89549790 |
| 105 | MP0003868_abnormal_feces_composition | 0.89109216 |
| 106 | MP0009697_abnormal_copulation | 0.88338040 |
| 107 | MP0008260_abnormal_autophagy | 0.85388218 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.84650053 |
| 109 | MP0003279_aneurysm | 0.84492785 |
| 110 | MP0006138_congestive_heart_failure | 0.83230149 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.81969440 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.81969440 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.81279152 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.80142717 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.80043364 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.78275977 |
| 117 | MP0009764_decreased_sensitivity_to | 0.77621877 |
| 118 | MP0000604_amyloidosis | 0.76456933 |
| 119 | MP0000747_muscle_weakness | 0.76195081 |
| 120 | MP0005266_abnormal_metabolism | 0.75517103 |
| 121 | MP0003959_abnormal_lean_body | 0.75477420 |
| 122 | MP0001756_abnormal_urination | 0.74466355 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.72211436 |
| 124 | MP0004272_abnormal_basement_membrane | 0.71398085 |
| 125 | MP0004087_abnormal_muscle_fiber | 0.71113771 |
| 126 | MP0004215_abnormal_myocardial_fiber | 0.70469252 |
| 127 | MP0000751_myopathy | 0.69975414 |
| 128 | MP0002972_abnormal_cardiac_muscle | 0.69656257 |
| 129 | MP0004147_increased_porphyrin_level | 0.67403967 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.67334182 |
| 131 | MP0004036_abnormal_muscle_relaxation | 0.67289374 |
| 132 | MP0005620_abnormal_muscle_contractility | 0.67127814 |
| 133 | MP0008469_abnormal_protein_level | 0.66702593 |
| 134 | MP0005452_abnormal_adipose_tissue | 0.65240317 |
| 135 | MP0002796_impaired_skin_barrier | 0.63748526 |
| 136 | MP0000749_muscle_degeneration | 0.61266596 |
| 137 | MP0000343_altered_response_to | 0.61246868 |
| 138 | MP0002060_abnormal_skin_morphology | 0.60891501 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60252387 |
| 140 | MP0002269_muscular_atrophy | 0.59932007 |
| 141 | MP0004084_abnormal_cardiac_muscle | 0.58848478 |
| 142 | MP0005164_abnormal_response_to | 0.58268204 |
| 143 | MP0010630_abnormal_cardiac_muscle | 0.56960208 |
| 144 | MP0003953_abnormal_hormone_level | 0.56591864 |
| 145 | MP0006035_abnormal_mitochondrial_morpho | 0.51500649 |
| 146 | MP0000249_abnormal_blood_vessel | 0.50966311 |
| 147 | MP0002168_other_aberrant_phenotype | 0.50712614 |
| 148 | MP0001853_heart_inflammation | 0.50058104 |
| 149 | MP0009384_cardiac_valve_regurgitation | 0.49763888 |
| 150 | MP0005595_abnormal_vascular_smooth | 0.49098472 |
| 151 | MP0004883_abnormal_blood_vessel | 0.47205072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 5.60265174 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.53080142 |
| 3 | Hyperlipoproteinemia (HP:0010980) | 5.24123949 |
| 4 | Hyperglycinuria (HP:0003108) | 5.17288128 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.15050668 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.86814468 |
| 7 | Hypoglycemic coma (HP:0001325) | 4.77903822 |
| 8 | Ketosis (HP:0001946) | 4.71145954 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.71114977 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.71114977 |
| 11 | Hyperammonemia (HP:0001987) | 4.65140753 |
| 12 | Complement deficiency (HP:0004431) | 4.45473339 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.42075855 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.40898723 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 4.37444705 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.36694071 |
| 17 | Hyperglycinemia (HP:0002154) | 4.36533853 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.35060230 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 4.34681045 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.34681045 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.34681045 |
| 22 | Epidermoid cyst (HP:0200040) | 4.18766782 |
| 23 | Hypolipoproteinemia (HP:0010981) | 4.13219512 |
| 24 | Ketoacidosis (HP:0001993) | 4.12401090 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09807290 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.90641481 |
| 27 | Orchitis (HP:0100796) | 3.72592637 |
| 28 | Axonal loss (HP:0003447) | 3.62534535 |
| 29 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.60808665 |
| 30 | Dicarboxylic aciduria (HP:0003215) | 3.60808665 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.48246714 |
| 32 | Myoglobinuria (HP:0002913) | 3.39906518 |
| 33 | Myositis (HP:0100614) | 3.35921776 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.32669005 |
| 35 | Optic neuritis (HP:0100653) | 3.32131572 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 3.32131572 |
| 37 | Abnormality of macrophages (HP:0004311) | 3.30784838 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.26081169 |
| 39 | Joint hemorrhage (HP:0005261) | 3.21707945 |
| 40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.16051672 |
| 41 | Abnormality of complement system (HP:0005339) | 3.13312870 |
| 42 | Dysostosis multiplex (HP:0000943) | 3.12947358 |
| 43 | Hypertriglyceridemia (HP:0002155) | 3.10550517 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 3.07464459 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 3.03497221 |
| 46 | Generalized aminoaciduria (HP:0002909) | 3.02611602 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.01427945 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.99991720 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 2.95065456 |
| 50 | Lethargy (HP:0001254) | 2.94864406 |
| 51 | Muscle fiber splitting (HP:0003555) | 2.94503384 |
| 52 | Skin nodule (HP:0200036) | 2.93985865 |
| 53 | Cerebral edema (HP:0002181) | 2.93175006 |
| 54 | Metabolic acidosis (HP:0001942) | 2.87571246 |
| 55 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87076204 |
| 56 | Nausea (HP:0002018) | 2.83197161 |
| 57 | Difficulty running (HP:0009046) | 2.82512966 |
| 58 | Stomatitis (HP:0010280) | 2.81574820 |
| 59 | Oligomenorrhea (HP:0000876) | 2.81021293 |
| 60 | Myocardial infarction (HP:0001658) | 2.80366506 |
| 61 | Rhabdomyolysis (HP:0003201) | 2.79607905 |
| 62 | Increased variability in muscle fiber diameter (HP:0003557) | 2.78513928 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76907296 |
| 64 | Vertebral compression fractures (HP:0002953) | 2.75449028 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.74532864 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74344259 |
| 67 | Nuclear cataract (HP:0100018) | 2.73247586 |
| 68 | Increased connective tissue (HP:0009025) | 2.71222846 |
| 69 | Fat malabsorption (HP:0002630) | 2.66127576 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.65334025 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 2.61053547 |
| 72 | Eczematoid dermatitis (HP:0000976) | 2.60490265 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.59995191 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.59995191 |
| 75 | Muscle fiber inclusion bodies (HP:0100299) | 2.59007600 |
| 76 | Nemaline bodies (HP:0003798) | 2.57430443 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.56127661 |
| 78 | Loss of speech (HP:0002371) | 2.54543226 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.53466702 |
| 80 | Acanthosis nigricans (HP:0000956) | 2.53070615 |
| 81 | Vomiting (HP:0002013) | 2.50308101 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.49840881 |
| 83 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.48957184 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.48777283 |
| 85 | Delayed CNS myelination (HP:0002188) | 2.46426948 |
| 86 | Hyperbilirubinemia (HP:0002904) | 2.44841792 |
| 87 | Pancreatitis (HP:0001733) | 2.44717995 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43105005 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43105005 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43105005 |
| 91 | Mutism (HP:0002300) | 2.39778304 |
| 92 | Mediastinal lymphadenopathy (HP:0100721) | 2.38188837 |
| 93 | Hepatic necrosis (HP:0002605) | 2.37741225 |
| 94 | Increased serum ferritin (HP:0003281) | 2.37459885 |
| 95 | Increased muscle lipid content (HP:0009058) | 2.36947654 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.35334706 |
| 97 | Gout (HP:0001997) | 2.35062039 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 2.34796761 |
| 99 | Renal cortical cysts (HP:0000803) | 2.33906998 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.32812589 |
| 101 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.30682439 |
| 102 | Hepatocellular carcinoma (HP:0001402) | 2.29995268 |
| 103 | Proximal tubulopathy (HP:0000114) | 2.29156106 |
| 104 | Neck muscle weakness (HP:0000467) | 2.28683178 |
| 105 | Hemorrhage of the eye (HP:0011885) | 2.28291140 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 2.23916448 |
| 107 | Bone cyst (HP:0012062) | 2.23649499 |
| 108 | Glomerulonephritis (HP:0000099) | 2.23466492 |
| 109 | Amyloidosis (HP:0011034) | 2.22750715 |
| 110 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22317974 |
| 111 | Mucopolysacchariduria (HP:0008155) | 2.22317974 |
| 112 | Type 1 muscle fiber predominance (HP:0003803) | 2.20910071 |
| 113 | Systemic lupus erythematosus (HP:0002725) | 2.20150727 |
| 114 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17705080 |
| 115 | Brushfield spots (HP:0001088) | 2.16701575 |
| 116 | Cholelithiasis (HP:0001081) | 2.14857387 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 2.14689305 |
| 118 | Hyperglycemia (HP:0003074) | 2.14393429 |
| 119 | Increased cerebral lipofuscin (HP:0011813) | 2.10483636 |
| 120 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10453862 |
| 121 | Abnormal gallbladder morphology (HP:0012437) | 2.09614090 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 2.08303186 |
| 123 | Polycythemia (HP:0001901) | 2.08148905 |
| 124 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.08103858 |
| 125 | Right ventricular cardiomyopathy (HP:0011663) | 2.06477409 |
| 126 | Colitis (HP:0002583) | 2.06159989 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05049180 |
| 128 | Hyperuricemia (HP:0002149) | 2.03632280 |
| 129 | Increased purine levels (HP:0004368) | 2.03632280 |
| 130 | Distal lower limb amyotrophy (HP:0008944) | 2.03350845 |
| 131 | Polygenic inheritance (HP:0010982) | 2.02849018 |
| 132 | Frequent falls (HP:0002359) | 2.00586200 |
| 133 | EMG: myopathic abnormalities (HP:0003458) | 2.00344744 |
| 134 | Vascular calcification (HP:0004934) | 1.99535340 |
| 135 | Bulbar palsy (HP:0001283) | 1.99110414 |
| 136 | Enlarged kidneys (HP:0000105) | 1.97910746 |
| 137 | Gastrointestinal infarctions (HP:0005244) | 1.97116523 |
| 138 | Fatigue (HP:0012378) | 1.96729446 |
| 139 | Abnormality of glycolysis (HP:0004366) | 1.95881445 |
| 140 | Increased serum pyruvate (HP:0003542) | 1.95881445 |
| 141 | Vasculitis (HP:0002633) | 1.95680104 |
| 142 | Acute encephalopathy (HP:0006846) | 1.95590159 |
| 143 | Steatorrhea (HP:0002570) | 1.95471245 |
| 144 | Hyporeflexia of lower limbs (HP:0002600) | 1.94572077 |
| 145 | Muscle stiffness (HP:0003552) | 1.93176212 |
| 146 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91866652 |
| 147 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91134608 |
| 148 | Gangrene (HP:0100758) | 1.90290349 |
| 149 | Exercise-induced myalgia (HP:0003738) | 1.89601910 |
| 150 | Disinhibition (HP:0000734) | 1.89490073 |
| 151 | Irritability (HP:0000737) | 1.89442114 |
| 152 | Cardiovascular calcification (HP:0011915) | 1.89420272 |
| 153 | Spontaneous abortion (HP:0005268) | 1.88570238 |
| 154 | Progressive neurologic deterioration (HP:0002344) | 1.87859982 |
| 155 | Cholecystitis (HP:0001082) | 1.87685653 |
| 156 | Abnormal gallbladder physiology (HP:0012438) | 1.87685653 |
| 157 | Pulmonary infiltrates (HP:0002113) | 1.87479267 |
| 158 | Sensorimotor neuropathy (HP:0007141) | 1.86398425 |
| 159 | Late onset (HP:0003584) | 1.85163481 |
| 160 | Glomerulopathy (HP:0100820) | 1.85089603 |
| 161 | Methylmalonic aciduria (HP:0012120) | 1.84813233 |
| 162 | Spastic diplegia (HP:0001264) | 1.84196818 |
| 163 | Insulin resistance (HP:0000855) | 1.83739220 |
| 164 | Purpura (HP:0000979) | 1.83507801 |
| 165 | Increased IgM level (HP:0003496) | 1.82674634 |
| 166 | Spinal rigidity (HP:0003306) | 1.81164766 |
| 167 | Esophageal varix (HP:0002040) | 1.81019889 |
| 168 | Elevated hepatic transaminases (HP:0002910) | 1.80079397 |
| 169 | Protrusio acetabuli (HP:0003179) | 1.79481293 |
| 170 | Mitral stenosis (HP:0001718) | 1.78638548 |
| 171 | Lipoatrophy (HP:0100578) | 1.78538198 |
| 172 | Episodic fever (HP:0001954) | 1.78511494 |
| 173 | Glycosuria (HP:0003076) | 1.78316020 |
| 174 | Abnormality of urine glucose concentration (HP:0011016) | 1.78316020 |
| 175 | Respiratory distress (HP:0002098) | 1.78168358 |
| 176 | Abnormality of iron homeostasis (HP:0011031) | 1.77178401 |
| 177 | Autoimmune thrombocytopenia (HP:0001973) | 1.75984591 |
| 178 | Hemoptysis (HP:0002105) | 1.74737450 |
| 179 | Gingivitis (HP:0000230) | 1.70209407 |
| 180 | Difficulty climbing stairs (HP:0003551) | 1.69272422 |
| 181 | Arterial thrombosis (HP:0004420) | 1.68686062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.52124328 |
| 2 | SIK1 | 5.14559213 |
| 3 | TRIB3 | 4.23598495 |
| 4 | CAMK1D | 3.51032425 |
| 5 | ERN1 | 3.26507491 |
| 6 | PKN2 | 2.91448664 |
| 7 | PDK3 | 2.81343370 |
| 8 | PDK4 | 2.81343370 |
| 9 | TAOK2 | 2.52542523 |
| 10 | PRPF4B | 2.47513602 |
| 11 | MOS | 2.39303623 |
| 12 | CAMK1G | 2.38636941 |
| 13 | FGFR4 | 2.31448454 |
| 14 | MAP3K14 | 2.31390703 |
| 15 | TESK1 | 2.28911721 |
| 16 | INSRR | 2.14505446 |
| 17 | ARAF | 2.01573788 |
| 18 | RIPK4 | 1.99886727 |
| 19 | BLK | 1.86829061 |
| 20 | IRAK4 | 1.81742929 |
| 21 | GRK7 | 1.81399158 |
| 22 | PIM2 | 1.80594373 |
| 23 | MYLK | 1.74240211 |
| 24 | PRKAA2 | 1.67872211 |
| 25 | PDK2 | 1.66464456 |
| 26 | MST1R | 1.61565324 |
| 27 | RIPK1 | 1.59157233 |
| 28 | LMTK2 | 1.58201243 |
| 29 | PIK3CA | 1.47547879 |
| 30 | IKBKE | 1.46652134 |
| 31 | ZAP70 | 1.43461965 |
| 32 | TAOK1 | 1.41443803 |
| 33 | IKBKB | 1.36037626 |
| 34 | TIE1 | 1.35408851 |
| 35 | TTN | 1.33653115 |
| 36 | FLT3 | 1.33527981 |
| 37 | LATS1 | 1.33124144 |
| 38 | OBSCN | 1.33047486 |
| 39 | TGFBR2 | 1.26335659 |
| 40 | MAP3K13 | 1.23047433 |
| 41 | MAP3K1 | 1.22085665 |
| 42 | PTK6 | 1.18161491 |
| 43 | FRK | 1.17051449 |
| 44 | PINK1 | 1.14094401 |
| 45 | IRAK2 | 1.13829696 |
| 46 | MAPK11 | 1.13666782 |
| 47 | NEK9 | 1.11811821 |
| 48 | TESK2 | 1.08940407 |
| 49 | FGFR2 | 1.08164789 |
| 50 | IRAK1 | 1.07640262 |
| 51 | PIK3CG | 1.04882424 |
| 52 | MAP2K4 | 1.04274764 |
| 53 | MATK | 1.04087630 |
| 54 | STK38L | 1.03825584 |
| 55 | CDC42BPA | 1.02903038 |
| 56 | DAPK2 | 1.01403271 |
| 57 | PHKG1 | 1.00574748 |
| 58 | PHKG2 | 1.00574748 |
| 59 | MAP3K7 | 0.96581107 |
| 60 | MAP4K1 | 0.96509147 |
| 61 | BMPR2 | 0.95222076 |
| 62 | PRKAA1 | 0.94628057 |
| 63 | MAP2K3 | 0.92006714 |
| 64 | ERBB4 | 0.90960518 |
| 65 | PDGFRA | 0.90898387 |
| 66 | MAPK12 | 0.89576877 |
| 67 | EPHB1 | 0.87187122 |
| 68 | JAK1 | 0.85720317 |
| 69 | JAK2 | 0.83869450 |
| 70 | KDR | 0.81842099 |
| 71 | EPHB2 | 0.80235306 |
| 72 | FGR | 0.79488162 |
| 73 | LIMK1 | 0.77252277 |
| 74 | MAP2K1 | 0.76262776 |
| 75 | TYK2 | 0.75888106 |
| 76 | ABL2 | 0.75066505 |
| 77 | PDPK1 | 0.75044691 |
| 78 | MAP3K3 | 0.74958059 |
| 79 | MET | 0.72473488 |
| 80 | PAK4 | 0.72430006 |
| 81 | STK10 | 0.70305405 |
| 82 | CHUK | 0.70178549 |
| 83 | FGFR3 | 0.69541967 |
| 84 | TXK | 0.69506486 |
| 85 | IRAK3 | 0.68759769 |
| 86 | MAP3K5 | 0.67551130 |
| 87 | PRKACG | 0.65314709 |
| 88 | HIPK2 | 0.65236231 |
| 89 | CDK6 | 0.64955615 |
| 90 | KSR2 | 0.62471818 |
| 91 | BRAF | 0.62368344 |
| 92 | EPHA3 | 0.59303776 |
| 93 | TBK1 | 0.58716814 |
| 94 | CSK | 0.57838416 |
| 95 | RET | 0.57349028 |
| 96 | IGF1R | 0.57113912 |
| 97 | LATS2 | 0.56587645 |
| 98 | MAPK4 | 0.56182948 |
| 99 | GSK3A | 0.55997566 |
| 100 | PDK1 | 0.51179853 |
| 101 | PRKD1 | 0.51118279 |
| 102 | NME2 | 0.49259322 |
| 103 | CDK9 | 0.47538901 |
| 104 | PRKCZ | 0.47089550 |
| 105 | GRK5 | 0.46711178 |
| 106 | MTOR | 0.45772179 |
| 107 | DAPK3 | 0.45452039 |
| 108 | PKN1 | 0.44710702 |
| 109 | MAPKAPK3 | 0.44435822 |
| 110 | SIK3 | 0.43656370 |
| 111 | CAMK1 | 0.43378666 |
| 112 | MAP2K6 | 0.43346136 |
| 113 | ILK | 0.42409090 |
| 114 | BMX | 0.42389114 |
| 115 | TAOK3 | 0.39663091 |
| 116 | PDGFRB | 0.39601154 |
| 117 | HCK | 0.39555219 |
| 118 | PAK3 | 0.39446938 |
| 119 | LYN | 0.38801633 |
| 120 | DMPK | 0.38701545 |
| 121 | FER | 0.38207253 |
| 122 | PTK2B | 0.37808025 |
| 123 | ICK | 0.36644423 |
| 124 | PTK2 | 0.34898187 |
| 125 | PAK1 | 0.34875053 |
| 126 | FGFR1 | 0.32674300 |
| 127 | CDK4 | 0.31569169 |
| 128 | SGK3 | 0.31138174 |
| 129 | PRKCH | 0.30457053 |
| 130 | CLK1 | 0.30388895 |
| 131 | CSF1R | 0.30003633 |
| 132 | CAMK2G | 0.29944362 |
| 133 | MAP3K6 | 0.29430824 |
| 134 | TRPM7 | 0.28721724 |
| 135 | EPHA2 | 0.27817986 |
| 136 | SYK | 0.27692712 |
| 137 | MAPKAPK2 | 0.27082507 |
| 138 | CAMKK2 | 0.26770350 |
| 139 | JAK3 | 0.26225180 |
| 140 | ABL1 | 0.25364787 |
| 141 | RPS6KB1 | 0.24510266 |
| 142 | MAPK7 | 0.24434002 |
| 143 | DDR2 | 0.23700849 |
| 144 | WNK4 | 0.23409759 |
| 145 | LRRK2 | 0.23323530 |
| 146 | GRK6 | 0.22633614 |
| 147 | STK3 | 0.22541320 |
| 148 | STK38 | 0.22294858 |
| 149 | MAP3K11 | 0.20639161 |
| 150 | ROCK1 | 0.19769494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.35171624 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.32072506 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.17142485 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.14364579 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.81946652 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.80748702 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.80016907 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.78489027 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70184214 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.60827898 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49974399 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.48436199 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.39809155 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.39661455 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36456010 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35497259 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34490695 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.34342298 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.33702807 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.32784248 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 2.26136680 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20525107 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 2.17558069 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 2.17502345 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.13404445 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.08905455 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05846020 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03450331 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.01274822 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00948908 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.91095683 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88676086 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87957478 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76515755 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.76323819 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74574237 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72891290 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72800154 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.71691261 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62345951 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53728725 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52883983 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.52086718 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.50714821 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48573533 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48129681 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.47650750 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45258053 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40347823 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.40210969 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38518239 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34452985 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34434838 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33755556 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31589844 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30793256 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28136285 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27951409 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27802940 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 1.25678012 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 1.24624724 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23496320 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22183114 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21990598 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21688095 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20790189 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15096257 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12967249 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10406560 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 1.09047337 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08957412 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08548683 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07829360 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06443842 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 1.01651274 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98465985 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97484416 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97382745 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.96775447 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.96146947 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92739385 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92647486 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89657061 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87857102 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86785332 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86706778 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.85207699 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.85185809 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84658727 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.84055839 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.80196458 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79767158 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.79674906 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77067347 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76535078 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75489804 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74517677 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73702742 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71621248 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71220881 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70673167 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67759123 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67220952 |
| 104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66950488 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66453797 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.66155261 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.65488066 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63842283 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62865822 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61692195 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60437218 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60338264 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.59984610 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59885798 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59545643 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59456433 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59049173 |
| 118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58015959 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57017970 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54099800 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47288739 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45586541 |
| 123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43038903 |
| 124 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40297229 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39610020 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39490870 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39274489 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38755855 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36947816 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.34018554 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33237603 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32210161 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31181199 |
| 134 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30597293 |
| 135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30497078 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29599407 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28135385 |
| 138 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.20180688 |
| 139 | Parkinsons disease_Homo sapiens_hsa05012 | 0.16306308 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12355139 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11936388 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.08459641 |
| 143 | Alzheimers disease_Homo sapiens_hsa05010 | 0.07227761 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.06973804 |
| 145 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.01549515 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1714354 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1610996 |
| 148 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1441061 |
| 149 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.1353343 |
| 150 | Huntingtons disease_Homo sapiens_hsa05016 | -0.1148550 |
| 151 | Amoebiasis_Homo sapiens_hsa05146 | -0.1128877 |
| 152 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1124261 |
| 153 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1049142 |
| 154 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0963143 |
| 155 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0846977 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0747653 |
| 157 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0345212 |
| 158 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0069086 |
| 159 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0046784 |

